MDS receives provisional anti-trust approval to sell MDS Analytical Technologies to Danaher

Approval a Significant Milestone Toward Close of Transaction

MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today announced that the Company has received provisional anti-trust approval from the United States Federal Trade Commission (FTC) for the proposed sale of MDS Analytical Technologies to Danaher Corporation (NYSE: DHR).

All other requisite regulatory approvals required for the completion of the acquisition have now been received.

The sale of MDS Analytical Technologies to Danaher, which was announced on September 2, 2009, is expected to close before the end of the first calendar quarter of 2010, subject to the satisfaction of conditions to closing.

Source:

MDS INC.

Posted in:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Danaher. (2019, June 19). MDS receives provisional anti-trust approval to sell MDS Analytical Technologies to Danaher. News-Medical. Retrieved on April 18, 2024 from https://www.news-medical.net/news/20100128/MDS-receives-provisional-anti-trust-approval-to-sell-MDS-Analytical-Technologies-to-Danaher.aspx.

  • MLA

    Danaher. "MDS receives provisional anti-trust approval to sell MDS Analytical Technologies to Danaher". News-Medical. 18 April 2024. <https://www.news-medical.net/news/20100128/MDS-receives-provisional-anti-trust-approval-to-sell-MDS-Analytical-Technologies-to-Danaher.aspx>.

  • Chicago

    Danaher. "MDS receives provisional anti-trust approval to sell MDS Analytical Technologies to Danaher". News-Medical. https://www.news-medical.net/news/20100128/MDS-receives-provisional-anti-trust-approval-to-sell-MDS-Analytical-Technologies-to-Danaher.aspx. (accessed April 18, 2024).

  • Harvard

    Danaher. 2019. MDS receives provisional anti-trust approval to sell MDS Analytical Technologies to Danaher. News-Medical, viewed 18 April 2024, https://www.news-medical.net/news/20100128/MDS-receives-provisional-anti-trust-approval-to-sell-MDS-Analytical-Technologies-to-Danaher.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Danaher net earnings increase 9% to $597 million in Q3 2013